GBS Venture Partners

GBS Venture Partners is a venture capital firm based in Melbourne, Australia, that specializes in financing early-stage life science, human healthcare, biotechnology, and medical technology companies. The firm manages $450 million in assets across multiple specialized venture funds, deploying capital into product development startups in exchange for equity stakes with targeted exit horizons of three to five years. Historically, the organization has raised significant capital pools from government programs and institutional investors, including a $42.5 million inaugural fund and a subsequent $65 million second vehicle backed by industry superannuation funds. Its investment portfolio features several notable healthcare and medical device developers, including the publicly listed Pharmaxis, AirXpanders, Neuromonics, and Endoluminal Sciences. GBS Venture Partners was originally founded in 1996 as a spin-out and later formalized under its current structure by co-founders Brigitte Smith and Dr. Geoff Brooke.